Reported 0 shares, down 466 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2021 | Reduced | 0 | -466 (-100.0%) | 0 | $0 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
25 managers reported EYEGATE PHARMACEUTICALS INC for Q3 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT LLC | Added | 237,477 | +222,654 | < 0.01% | $534,000 | 8 qtrs |
| VANGUARD GROUP INC | Added | 151,702 | +23,935 | < 0.01% | $341,000 | 6 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | New | 51,300 | +51,300 | < 0.01% | $115,000 | 1 qtr |
| JANE STREET GROUP LLC | New | 34,742 | +34,742 | < 0.01% | $78,000 | 1 qtr |
| Sassicaia Capital Advisers LLC | New | 25,000 | +25,000 | 0.16% | $56,000 | 1 qtr |
| BlackRock Inc | Unchanged | 20,981 | 0 | < 0.01% | $47,000 | 9 qtrs |
| Tuttle Capital Management LLC | New | 18,174 | +18,174 | 0.05% | $41,000 | 1 qtr |
| Tower Research Capital LLC TRC | New | 13,832 | +13,832 | < 0.01% | $31,000 | 1 qtr |
| XTX Topco Ltd | New | 13,867 | +13,867 | 0.01% | $31,000 | 1 qtr |
| CREDIT SUISSE AG | New | 10,250 | +10,250 | < 0.01% | $23,000 | 1 qtr |
Filing details and methodology As reported
- Report period
- September 30, 2021
- Filed
- November 15, 2021
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.